Clinical trial · Observational
Epidemiology and Prognostic Analysis of Chinese Cancer Patients With Cancer-related Fatigue
NCT07656324CI-TRIAL-00115227recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This investigator-initiated study aims to evaluate the incidence and severity of cancer-related fatigue (CRF) in patients with malignant tumors, to analyze the influencing factors of CRF, and to explore its impact on anti-tumor treatment and prognosis.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| No Interventions | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Patients with malignant tumors
- description
- 1. Male or female, aged 18 years or older. 2. Able to understand the purpose of this survey study, willing to participate, and able to sign an informed consent form. 3. Malignant tumor confirmed histologically or cytologically.
- interventionNames
- Other: No Interventions
Primary outcomes (1)
- measure
- The incidence of cancer-related fatigue (CRF) in tumor patients.
- timeFrame
- Baseline
- description
- The incidence of cancer-related fatigue (CRF) in tumor patients.
Secondary outcomes (5)
- measure
- The severity grading of cancer-related fatigue (CRF) in tumor patients across different tumor types and multiple treatment settings.
- timeFrame
- Baseline
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: 1. Male or female, aged 18 years or older. 2. Able to understand the purpose of this survey study, willing to participate, and able to sign an informed consent form. 3. Malignant tumor confirmed histologically or cytologically. Exclusion Criteria: 1. Pregnant or breastfeeding women. 2. Patients with acute or chronic infections, or those with other serious medical conditions that, in the investigator's judgment, make them unsuitable for this study. 3. Patients with two or more concurrent malignant tumors (excluding the following: cured basal cell carcinoma of the skin, carcinoma in situ of the cervix, and papillary thyroid carcinoma). 4. Patients with psychiatric illness or mental disorders, poor compliance, or who are unable to cooperate and report treatment responses. 5. Patients with severe organic disease or major organ failure, such as decompensated heart, lung, liver, or kidney failure. 6. Patients with other conditions that, in the investigator's opinion, make them unsuitable for participation in this study.
References
Publications (0)
Data not yet available
No reference posted for this study.